Engage Aotearoa

Category Archives: Psychiatric Medication

New Study: no such thing as chemical imbalance?

A recent study looked at the “Effects of a chemical imbalance causal explanation on individuals’ perceptions of their depressive symptoms.”

A group of participants was given “a bogus but credible biological test demonstrating their depressive symptoms to be caused, or not caused, by a chemical imbalance in the brain”.

“Results showed that chemical imbalance test feedback failed to reduce self-blame, elicited worse prognostic pessimism and negative mood regulation expectancies, and led participants to view pharmacotherapy as more credible and effective than psychotherapy. The present findings add to a growing literature highlighting the unhelpful and potentially iatrogenic effects of attributing depressive symptoms to a chemical imbalance.”

In short, it might be harmful to believe that you have a chemical imbalance. A diagnosis of “depression caused by chemical imbalance” might cause depression.

Study authors:

Joshua J. Kempa, James J. Lickelb, Brett J. Deacona

Link here.

 

 

 

Share Your Experience of High Risk Medicines

This is a request for patients/consumers/family/whanau interested in being interviewed to tell their story about their experience of being on what are known as ‘high risk medicines’.

As you may know in May 2013 the Commission launched a national patient safety campaign to reduce harm from falls, healthcare associated infections, surgery, and medication.

As part this campaign, the Commission wants to develop consumer stories involving high-risk medicines.  High-risk medicines include anticoagulants (eg, warfarin, heparin), opioids (eg, morphine, oxycodone, and fentanyl), insulin, concentrated potassium injection and disease modifying anti-rheumatic drugs (eg, methotrexate, azathioprine).

Listening to the experiences of health consumers is at the heart of consumer engagement within the health system. The stories give staff and decision-makers a window into the consumer’s world, their experience of the health service and their perceptions of the quality of care they received. You might like to share things like:

  • How did you come to be on this medicine
  • What it is like to be put on these medicines
  • Whether you had explained to you in a way you can understand what the side effects and risks might be
  • Whether you had explained to you in a way you can understand what the medicine is for
  • What you have learned about taking this medicine, ie how your life has been affected
  • How you are getting on now taking this medicine
  • What advice would you give to anyone else taking the same medicine as you

The Commission wants to find patients and clinicians willing to be involved and tell their stories.  These stories will be provided to a wide range of people working in the health and disability sector, and will be aimed at health policy and decision-makers as well as the general public.

The commitment required is a couple of phone calls as way of introduction, setting up the interview etc., an initial interview, and review of the written story to make sure you are happy with it.  If it is an audio visual one then obviously the commitment may require some travelling to where you can be filmed and things like travel and reimbursement will be discussed.

If you are interested, or want more information please ring Natalie Ganley on 021 322 205 or e mail her at Natalie.ganley@hqsc.govt.nz where you will be able to find out more and have all your questions answered. Natalie works Monday to Wednesday in the Auckland office (of the Health Quality & Safety Commission) where the land line is Ph: 09 580 9075

Update to The Experiences of Antipsychotic Medication Survey

The Experiences of Antipsychotic Medication Survey is now open to all NZ adults over 18 who are living in the community, including people with Compulsory Treatment Orders.
Find out more at http://www.teamstudy.co.nz
Everything you need to take part is available on the website.

Please share this invitation to take part with your networks.

Contact:
Miriam Larsen-Barr
Ph: 09 373 7599 ext 86890
Email: mbar114@aucklanduni.ac.nz

TEAMS

Survey Open: NZ Study Explores Experiences of Antipsychotic Medication

The Experiences of Antipsychotic Medication Survey is now open for responses from NZ adults over 18 who take or have taken antipsychotic medication.

Find out more at www.teamstudy.co.nz

A full Participant Information Sheet is available on the website.

Please share this invitation to take part with your networks.

TEAMS

Contact

Miriam Larsen-Barr
Ph: 09 373 7599 ext 86890
Email: mbar114@aucklanduni.ac.nz

.

Emotional side-effects of antidepressants reported by more than 50% of largest sample surveyed to date

MEDIA RELEASE – UNIVERSITY OF LIVERPOOL – 18.02.2014

A survey of 1829 New Zealanders prescribed antidepressants, the largest sample ever surveyed, has found high rates of emotional and interpersonal adverse effects. The abstract of the paper, just published online in Psychiatry Research, follows:

Background: In the context of rapidly increasing antidepressant use internationally, and recent reviews raising concerns about efficacy and adverse effects, this study aimed to survey the lived experience of the largest sample of AD recipients to date.

Methods: An online questionnaire about experiences with, and beliefs about, antidepressants was completed by 1829 adults who had been prescribed antidepressants in the last five years.

Results: Eight of the 20 adverse effects studied were reported by over half the participants; most frequently Sexual Difficulties (62%) and Feeling Emotionally Numb (60%). Percentages for other effects included: Feeling Not Like Myself – 52%, Reduction In Positive Feelings – 42%, Caring Less About Others – 39%, Suicidality – 39% and Withdrawal Effects – 55%. Total Adverse Effect scores were related to younger age, lower education and income, and type of antidepressant, but not to level of depression prior to taking antidepressants.

Conclusions: The adverse effects of antidepressants may be more frequent than previously reported, and include emotional and interpersonal effects. Lead researcher, Professor John Read (Institute of Psychology, Health and Society; University of Liverpool) comments: “The medicalization of sadness and distress has reached bizarre levels. One in ten people in some countries are now prescribed antidepressants each year.”

“While the biological side effects of antidepressants, such as weight gain and nausea, are well documented, the psychological and interpersonal effects have been largely ignored or denied. They appear to be alarmingly common.”

“Effects such as feeling emotionally numb and caring less about other people are of major concern. Our study also found that people are not being told about these effects when prescribed the drugs.”

“Our finding that over a third of respondents reported suicidality ‘as a result of taking the antidepressants’ suggests that earlier studies may have underestimated the problem.”

Over half (55%) of young people (18-25years) reported suicidality.

“Our sample was not biased towards people with an axe to grind about anti-depressants; 82% reported that the drugs had helped alleviate their depression.”

readj@liv.ac.uk

Read, J., Cartwright, C., Gibson, K. (2014). Adverse emotional and interpersonal effects reported by 1,829 New Zealanders while taking antidepressants.  Psychiatry Research

http://dx.doi.org/10.1016/j.psychres.2014.01.042

Highlights from Engage Aotearoa on Facebook

Here are just a few of the posts shared on the Engage Aotearoa Facebook Page this week.

From Jake the Dog, created by Pendleton Ward.

Jake the Dog is an animated kids’ show in the USA…

Service-User shares Open Letter to their Psychiatrist

Engage Aotearoa has received an open letter to share from a member of the community who has been using one of the Community Mental-Health Services in Auckland. The letter will be read in a week or two to the clinician involved. But they wanted to share their thoughts further than that.

It is sad to admit,” says service director, Miriam Larsen-Barr, “but we know the experiences of disempowerment and lack of choice highlighted in this letter are rather widespread. We receive regular emails from community members informing us of similar experiences. People don’t want to complain. They want to be heard, valued, respected, listened to and worked with, not worked on. Perhaps if we bring our voices together and get behind each other more we can help turn that balance of power around.

Open Letter to a NZ Psychiatrist

Dear Doctor

I have written you this letter because every time I attempt to express myself while inside the walls of a mental health facility my words dry up. I choke on my frustration, I sigh at the futility of trying to explain myself to people who have never understood me and I give up. Instead I have put into words well in advance what I want to say to you, so that the message comes across clear. I have written the words down so I can read them calmly, and you will hear them not as mania or psychosis or the rant of a lunatic, but so you will hear them as a carefully prepared statement, and maybe just a few will sink in.

Let me begin by discussing my views on psychiatry in general, so that you understand I have no respect for anyone in your position. I admit, it’s true I have a personal prejudice against psychiatrists, so it would have been hard for you to earn my respect. Here’s why. I think that the entire history of psychiatry has done more harm than good. I think that psychiatry today does more harm than good. You forcefully medicate and detain people against their will, and you claim it helps them. You habituate people to substances which you have absolutely no idea how to help them discontinue. And you repeatedly ignore our service user requests for our own courses of treatment, while claiming you know better because of your education. You think you have a better knowledge of what’s good for me than I have for myself. And you think it because you’re sure you’re better than me in some way, less broken, more together, or more sane. You think my history proves I’m infantile or incapable, and your first and most strong desire is to convince me and make me accept I’m infantile and incapable. Every psychiatrist I have ever seen has been a broken record, and every time I’ve asked for help to meet my own health goals, I’m told I have the wrong goals.

So now I have to come to you personally, doctor. The first memory I have of our meeting, I remember you telling me that because of my history, it seemed obvious to you I would need medication for the rest of my life. Do you tell this to every service user the first time you meet them, Doctor? I’m glad my file is so complete and reliable that you can come to a conclusion about me and the rest of my life based on a few notes that other people have written about me. It’s a bit of a pity that my hopes, dreams, desires, wishes and aspirations don’t come into it at all.

It’s also a pity that you don’t share the rest of your expertise with your patients. Surely you learned something in all that time at university about diet or exercise or meditation or mediation or self-awareness, or in fact any way to flourish other than taking a happy pill. You must have some knowledge from your personal experience of dealing with distress or family members in need. You must have some idea about how to address the skeletons in my closet in a friendly and welcoming environment with someone I feel I can talk to.

Because if you don’t have any advice for me other than what the brand of the day is from the pharmaceutical company who gave you that free pad to write on and coffee mug to drink out of, I really am sad. Because you might as well be a pill vending machine. And maybe one day, when you’re a little older and wiser, you’ll count the years of time you stole from your doped up patients, not to mention the years you took off the end of their lives, and you might feel a little sad too.

Sincerely Yours

International Petition Demands “Let us see Drug Data! Drug hazards are not trade secrets”

A petition has been making its way around the internet urging drug companies to stop lawsuits blocking public access to drug trial data. The petition names physical health medications, but this issue is also highly relevant to the availability of drug trial data about psychiatric medications.

The petitioner, David Healy of Cardiff, Wales writes: 

Drug companies maximize the sales of new drugs by hyping their benefits while downplaying significant risks. In 2010 the European Medicines Agency began releasing patient-level data from the clinical trials used to approve new medicines in Europe – a development hailed by American and European researchers and researchers around the world as a major step towards drug safety.

This process has been shut down by a lawsuit taken by two American corporations – AbbVie, makers of Humira, the number one selling medication in the world with projected sales of $10 billion in 2013; and InterMune, whose pulmonary-fibrosis drug Esbriet has recently been approved in Europe at a cost of over $40,000 per year.

AbbVie and InterMune have filed suit to deny access to the data from their trials on the benefits and harms of these drugs, claiming these vital facts are “trade secrets” whose release would harm their profits. Their action has led to the shutdown of the entire public-access program, leaving millions of patients worldwide, and their doctors, in the dark.

We call on AbbVie and InterMune to drop their European Union lawsuit and release all patient level data on Humira, Esbriet and their other products. Vital data on drug safety should never be hidden as a “trade secret.” By copying this petition to President Barack Obama and members of his Cabinet we call on them to ensure that meaningful public access to clinical trial data becomes the policy of the FDA and is written into any international trade agreements governing the sale of prescription drugs and devices.

Copies to:
President Barack Obama;
Margaret Hamburg, M.D., Commissioner, Food & Drug Administration;
Secretary General Ban Ki Moon, United Nations;
World Health Organization Director Dr Margaret Chan.

Click here to sign the petition.

Health Select Committee Meeting About Petition for Better Mental-Healthcare Choices in NZ

Update: The Health Select Committee is not accepting submissions from the public for their meeting on the Petition for Better Mental-Healthcare Choices in NZ at this stage, as was advertised in the August 5th notice below. Submissions are to be accepted only from the petitioner (Annie Chapman) and the Ministry of Health.

As public submissions are typically invited, the team at Engage thought the same would be true of the meeting about the Petition for Better Mental-Healthcare Choices. We apologise for any inconvenience and frustration caused to anyone who had prepared or sent a submission in.

Click here to read Engage Aotearoa’s Submission on the Petition for Better Mental-Healthcare Choices.

~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~

5.08.2013

The Petition for Better Mental-Healthcare Choices in NZ had it’s first reading by the Health Select Committee on the 10th of July and submissions are invited by the 23rd of August.

Find out more about making a submission here.

If these options are difficult for you, contact the chairperson of the Health Select Committee Paul Hutchison paul.hutchison@parliament.govt.nz 

Contact Annie Chapman for more information on hikoiforhealth@gmail.com 

Click here to visit the Hikoi website.

Petition for Better Mental-Healthcare Choices Presented to Parliament: What Next?

PetitionPresentationPhoto

Annie Chapman completed her Hikoi for Better Mental-Healthcare Choices on Tuesday the 11th of July and presented the final Petition for Better Mental-Healthcare Choices to members of parliament on the steps of the Beehive.

Chapman writes, “Well, the deed is done!! Six months after setting off from Cape Reinga, I handed over the paper petition with 1053 signatures to Paul Hutchison, who presented it to Parliament today. I will hear back from the Health Select Committee, probably in just over a week, of when the petition will be considered by the Committee and will be invited to make a submission at that time.

The petition presentation began with the final leg of the Hikoi as Annie made her way from the Botanic Rose Gardens to the Beehive with a collection of supporters. The procession reached parliament at midday where they were joined by a crowd of about 20 and at 12.30 the politicians arrived: Dr Paul Hutchison (National MP and chair of the Health Select Committee); Annette King (Labour Spokesperson for Health and member of the H.S.C.) Barbara Stewart (NZ First M.P. and member of H.S.C.); Dr Jian Yang (National M.P. and deputy chair of H.S.C.) and Louisa Wall (Labour M.P for Manurewa).

You can still help the Hikoi get results by making a submission to the health select committee about the Petition for Better Mental-Healthcare Choices.

Contact Annie Chapman for more information on hikoiforhealth@gmail.com

Email chairperson of Health Select Committee Paul Hutchison paul.hutchison@parliament.govt.nz